Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2025-12-24 @ 4:21 PM
NCT ID:
NCT05094466
Eligibility Criteria:
Inclusion Criteria:
* ELIGIBLE IN-DEPTH INTERVIEW PARTICIPANTS: Any church leader, such as pastors, minister, church secretary, health ministry leader, youth leader, deacons, ministry leader, director
* PARENT-CHILD DYADS: Be parent/caregiver (legal parent or custodial grandparent; male or female) and child willing to participate
* PARENT-CHILD DYADS: Live together in the same household
* PARENTS/CAREGIVERS: Self-identify as a racial ethnic minority (i.e., black or African American or Hispanic)
* PARENTS/CAREGIVERS: Parent or caregiver age 18 through 65 years old
* PARENTS/CAREGIVERS: Are obese (body mass index \[BMI\] \>= 30)
* PARENTS/CAREGIVERS: Are not currently participating in a physical activity (PA), diet, or weight management program
* PARENTS/CAREGIVERS: Enroll with a child aged 10-16 years
* PARENTS/CAREGIVERS: Have a valid home address, telephone number, and internet access
* PARENTS/CAREGIVERS: Are able to speak, read, and write in English
* CHILDREN: They are aged between 10-16 years
Exclusion Criteria:
* PARENTS/CAREGIVERS: They are currently pregnant or thinking about becoming pregnant during study period
* PARENTS/CAREGIVERS: They present any contraindications for exercise based on responses to the PA Readiness Questionnaire
* PARENTS/CAREGIVERS: Principal investigator (PI) determines that parent/caregiver is unsuitable for the study for reasons not otherwise stated in the protocol
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
10 Years
Study:
NCT05094466
Study Brief:
Protocol Section:
NCT05094466